Name: Latest research reports of Dr. Reddy's Laboratories Ltd. authored by Axis Direct and published by - Trendlyne research reports.
Item: Dr. Reddy's Laboratories Ltd.
Rating: 3
Author: Axis Direct

Summary	Date	Stock	Author	LTP	Target	Price at reco (Change since reco%)	Upside(%)	Type	Report	Discuss
	01 Sep 2025	Dr. Reddy's Labs	Consensus Share Price Target	1260.10	1287.88	-	2.20	hold	pdf Detailed Estimates
	30 Oct 2023	Dr. Reddy's Labs	Axis Direct Target	1260.10	5850.00	5345.35 (-76.43%)	Target met	Hold	pdf post cache	Broker Report Result Update:Dr Reddys Labs Axis Direct We believe the company's strategy of investing in various businesses may provide growth in the long term pdf Copy Link Share on Share on Share on Share on Alert
	30 Oct 2023	Dr. Reddy's Labs	BOB Capital Markets Ltd. Target	1260.10	5500.00	5345.35 (-76.43%)	Target met	Hold	pdf post cache	Broker Report Dr Reddy's Labs (HOLD): One-offs fuel PAT beat; India business still soft BOB Capital Markets Ltd. Q2 revenue in line but PAT outdid consensus by 22% on account of PLI benefits, litigation settlement and interest income pdf Copy Link Share on Share on Share on Share on Alert
	29 Oct 2023	Dr. Reddy's Labs	Prabhudas Lilladhar Target	1260.10	5300.00	5397.30 (-76.65%)	Target met	Sell	pdf post cache	Broker Report DR REDDY'S LABS Prabhudas Lilladhar pdf Copy Link Share on Share on Share on Share on Alert
	28 Oct 2023	Dr. Reddy's Labs	ICICI Securities Limited	1260.10	6000.00	5397.30 (-76.65%)	Target met	Accumulate	pdf post cache	Broker Report Cost pressure dents margins ICICI Securities Limited Dr. Reddy’s Laboratories’ (DRL) Q2FY24 gross and EBITDA margins were down 198bps/273bps YoY to 58.7%/28.9%, respectively. US price erosion, acquisition of Mayne Pharma and higher SG&A investments dented margins. pdf Copy Link Share on Share on Share on Share on Alert
	28 Oct 2023	Dr. Reddy's Labs	Motilal Oswal Target	1260.10	5400.00	5397.30 (-76.65%)	Target met	Neutral	pdf post cache	Broker Report Niche products lead to superior margins Motilal Oswal pdf Copy Link Share on Share on Share on Share on Alert
	24 Aug 2023	Dr. Reddy's Labs	Geojit BNP Paribas Reco Target	1260.10	6212.00	5907.15 (-78.67%)	Target met	Hold	pdf post cache	Broker Report DR. REDDY'S LABORATARIES Geojit BNP Paribas pdf Copy Link Share on Share on Share on Share on Alert
	27 Jul 2023	Dr. Reddy's Labs	Motilal Oswal Target	1260.10	5240.00	5507.00 (-77.12%)	Target met	Neutral	pdf post cache	Broker Report Sharp off-take in NA/Russia drive earnings Motilal Oswal pdf Copy Link Share on Share on Share on Share on Alert
	27 Jul 2023	Dr. Reddy's Labs	SMC online	1260.10		5507.00 (-77.12%)	Pre-Bonus/ Split	Results Update	pdf post cache	Broker Report Dr. Reddys Laboratories SMC online pdf Copy Link Share on Share on Share on Share on Alert
	27 Jul 2023	Dr. Reddy's Labs	Axis Direct Target	1260.10	6000.00	5507.00 (-77.12%)	Target met	Hold	pdf post cache	Broker Report Result Update:Dr Reddys Labs Axis Direct We have HOLD on the stock pdf Copy Link Share on Share on Share on Share on Alert
	27 Jul 2023	Dr. Reddy's Labs	ICICI Securities Limited Reco Target	1260.10	6000.00	5475.65 (-76.99%)	Target met	Accumulate	pdf post cache	Broker Report Better volumes in US drives margins ICICI Securities Limited Dr. Reddy’s (DRL) delivered a strong beat in EBITDA and profit, driven by incremental sales from its base product portfolio and gRevlimid in the US. gRevlimid continues to lift overall margins; however, additional sales from products that are in shortage in the US improved base business margins in Q1FY24. pdf Copy Link Share on Share on Share on Share on Alert
more loading

Dr. Reddy's Laboratories Ltd. share price target

Dr. Reddy's Laboratories Ltd. has an average share price target of 1278.56. The consensus estimate represents an upside of 1.46% from the last price of 1260.10. View 17 reports from 9 analysts offering long-term price targets for Dr. Reddy's Laboratories Ltd..

Result Update:Dr Reddys Labs

Dr Reddy's Labs (HOLD): One-offs fuel PAT beat; India business still soft

DR REDDY'S LABS

Cost pressure dents margins

Niche products lead to superior margins

DR. REDDY'S LABORATARIES

Sharp off-take in NA/Russia drive earnings

Dr. Reddys Laboratories

Result Update:Dr Reddys Labs

Better volumes in US drives margins

Advisor Screeners